Fate Therapeutics (FATE) Earnings
|
Expand Research on FATE
| Next EPS Date | 8/5/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +10.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | N/A | -$0.27 | N/A | N/A | $1.3M | N/A | N/A | N/A | ||
| 5/11/26 |
Q126 | N/A | -$0.28 | N/A | N/A | $1.24M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | N/A | -$0.28 | N/A | N/A | $1.24M | N/A | N/A | N/A | ||
| 5/6/26 |
Q126 | N/A | -$0.28 | N/A | N/A | $1.24M | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | -$0.27 | N/A | N/A | $1.25M | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$0.30 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 11/3/25 |
Q325 | N/A | -$0.30 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.30 | N/A | N/A | $1.36M | N/A | N/A | N/A |
